Which has grown faster, COO or MRNA?

Over the past five years, COO grew revenue faster — COO at a 9.73% CAGR versus MRNA at -2.60%.

Is COO or MRNA more profitable?

COO runs the higher net margin — COO at 5.57% versus MRNA at -143.55%.

Which has been the better investment, COO or MRNA?

Over the past 5-year, COO delivered the higher annualized total return — COO at 5.23% versus MRNA at -25.58%. Past performance doesn't predict future results.

The Cooper Companies, Inc. (COO) vs Moderna, Inc. (MRNA)

COO leads on 9 of 10 compared metrics.

A side-by-side comparison of The Cooper Companies, Inc. and Moderna, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 14, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

COO

The Cooper Companies, Inc.

Total return — COO vs MRNA

growth of $100 · last 8y

COO -2.0%MRNA +168.3%MRNA compounded faster

COO MRNA

COO vs MRNA: by the numbers

•MRNA is the larger company ($19.80B vs $13.24B market cap).
•COO is profitable (5.57% net margin) while MRNA runs a net loss (-143.55%).
•COO grew revenue faster over the past five years (9.73% vs -2.60% CAGR).

Which is better, COO or MRNA?

Metric tally: COO 9 · MRNA 1

It depends on what you're optimizing for:

GrowthCOO(faster 5Y revenue CAGR)

QualityCOO(higher ROIC)

Metrics side by side

Valuation

Metric	COO	MRNA
P/E ratio	57.53	—
Forward P/E	14.67	—
P/S ratio	3.13●	8.86
P/B ratio	1.61●	2.66
EV / EBITDA	17.97	—
FCF yield	4.30%	—

Profitability

Metric	COO	MRNA
Gross margin	64.37%●	-13.89%
Operating margin	11.77%●	-153.35%
Net margin	5.57%●	-143.55%
ROE	2.86%●	-43.12%
ROIC	3.98%●	-29.70%

Growth (annualized)

Metric	COO	MRNA
Revenue CAGR (5Y)	9.73%●	-2.60%
EPS CAGR (5Y)	-17.30%	—
FCF CAGR (5Y)	6.61%	126.92%●
Total return CAGR (5Y)	-6.25%●	-25.58%

Frequently asked

Which is better, COO or MRNA?: It depends on your goal. growth: COO (faster 5Y revenue CAGR); quality: COO (higher ROIC). Across all compared metrics, COO leads 9 to 1.
Which has grown faster, COO or MRNA?: Over the past five years, COO grew revenue faster — COO at a 9.73% CAGR versus MRNA at -2.60%.
Is COO or MRNA more profitable?: COO runs the higher net margin — COO at 5.57% versus MRNA at -143.55%.
Which has been the better investment, COO or MRNA?: Over the past 5-year, COO delivered the higher annualized total return — COO at 5.23% versus MRNA at -25.58%. Past performance doesn't predict future results.

Go deeper

Full COO analysis Full MRNA analysis Interactive comparison tool

Dig into the metrics

Cooper Companies P/E ratio Moderna P/E ratio Cooper Companies dividend yield Moderna dividend yield Cooper Companies ROE Moderna ROE Cooper Companies operating margin Moderna operating margin Cooper Companies revenue growth Moderna revenue growth Cooper Companies free cash flow Moderna free cash flow

Cooper Companies & Moderna appear in these rankings

Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 14, 2026.